GERI-KOT- sennosides tablet

Држава: Сједињене Америчке Државе

Језик: Енглески

Извор: NLM (National Library of Medicine)

Купи Сада

Активни састојак:

SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)

Доступно од:

Geri-Care Pharmaceutical Corp

Пут администрације:

ORAL

Тип рецептора:

OTC DRUG

Терапеутске индикације:

Laxative - relieves occasional constipation (irregularity) - generally produces bowel movement in 6 to 12 hours

Статус ауторизације:

OTC monograph not final

Карактеристике производа

                                GERI-KOT- SENNOSIDES TABLET
GERI-CARE PHARMACEUTICAL CORP
----------
GC 451B 415
ACTIVE INGREDIENT (IN EACH TABLET)
Sennosides 8.6 mg
PURPOSE
Laxative
USES
relieves occasional constipation (irregularity)
generally produces bowel movement in 6 to 12 hours
WARNINGS
DO NOT USE
for more than 1 week unless directed by a doctor.
ASK A DOCTOR BEFORE USE IF YOU
• have abdominal pain, nausea or vomiting
• have noticed a sudden change in bowel habits that lasts over 2
weeks
STOP USE AND ASK A DOCTOR IF
you have rectal bleeding
or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.
IF PREGNANT OR BREAST-FEEDING, ask a health professional before use.
KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help
or contact a
Poison Control Center right away.
DIRECTIONS
• do not exceed 8 tablets in 24 hours
AGE
STARTING DOSE
MAXIMUM DOSE
adults and children
12 years of age and
older
2 tablets once a day preferably at
bedtime; increase as needed, or as
directed by a doctor
4 tablets in the
morning and 4 tablets
at bedtime
children under 12
years
ask a doctor
OTHER INFORMATION
EACH TABLET CONTAINS: calcium 30 mg
Tamper Evident: Do not use if imprinted seal under cap is missing or
broken
store at 20°C-25°C (68°F-77°F)
INACTIVE INGREDIENTS
croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium
stearate,
microcrystalline cellulose, silica, talc, triacetin
PACKAGE LABEL
GERI-KOT
sennosides tablet
PRODUCT INFORMATION
PRODUCT TYPE
HUMAN OTC DRUG
ITEM CODE (SOURCE)
NDC:57896-415
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRENGTH
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)
SENNOSIDES
8.6 mg
INACTIVE INGREDIENTS
INGREDIENT NAME
STRENGTH
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
Geri-Care Pharmaceutical Corp
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
MAGNESIUM STEARATE (UNII: 70097M6I30)
TALC (UNII: 7SEV7J4
                                
                                Прочитајте комплетан документ
                                
                            

Обавештења о претрази у вези са овим производом

Погледајте историју докумената